Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
L’Oréal’s share price appreciated by over 40% in 2023, and at the beginning of 2024 it was trading moderately above our fair value. We had trimmed...
— Matthew Berry
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on L'Oréal
No other institutional pitches found for this ticker yet.
More institutional theses from Aoris International Fund
The manager presents Telstra as a cautionary tale of a monopoly-like business that became complacent due to a lack of competition. Protected by its...
IBM is analyzed as an example of how a dominant, highly protected recurring revenue stream can breed organizational complacency. Despite identifying the...
CDW's pandemic-era growth masked a structural vulnerability caused by its heavy exposure to physical hardware sales. As customer demands...